Posterior Epistaxis Diagnosis and Management

Clinical Characteristics

The American Academy of Otolaryngology-Head and Neck Surgery suggests that posterior epistaxis accounts for 5-10% of all nosebleeds and is more common in older patients with hypertension, often presenting as more difficult to control bleeding 1, 2, 3
The American College of Cardiology recommends considering hypertension as a strong association with posterior epistaxis, with patients having a increased risk of epistaxis requiring hospital visits 4

The American Academy of Otolaryngology-Head and Neck Surgery indicates that Hereditary Hemorrhagic Telangiectasia (HHT) requires visible telangiectasias on nasal or oral mucosa, which are not mentioned in this presentation, and typically presents with recurrent bilateral nosebleeds starting in childhood or adolescence 5
The American Academy of Otolaryngology-Head and Neck Surgery suggests that nasal hemangiomas would present with a visible mass lesion on examination, typically causing unilateral obstruction with associated symptoms like facial pain, and are uncommon causes of epistaxis 4

The American Academy of Otolaryngology-Head and Neck Surgery recommends identifying bleeding location, as posterior epistaxis originates from sites not visible on anterior rhinoscopy, requiring nasal endoscopy for definitive diagnosis 2, 4
The American Heart Association suggests monitoring but not aggressively lowering blood pressure acutely, as excessive reduction can cause renal, cerebral, or coronary ischemia in patients with chronic hypertension 4
The American College of Cardiology recommends assessing for anticoagulation status, as 15% of epistaxis patients are on long-term anticoagulation, which significantly impacts management 1, 3

The European Society of Cardiology notes that while the causal relationship between hypertension and epistaxis remains controversial, the association is well-established with prevalence rates of hypertension among epistaxis patients ranging from 17-67% 6

The American Heart Association recommends that blood pressure should be monitored but decisions about control must be based on bleeding severity and individual comorbidities, as aggressively lowering blood pressure acutely during active epistaxis can cause or worsen renal, cerebral, or coronary ischemia in patients with chronic hypertension 6